Piperonyl Butoxide
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Piperonyl Butoxide
Piperonyl Butoxide: Known uses and market status in Canada
Summary
The TxGNN model has no candidate with a score of 0.99 or higher for Piperonyl Butoxide, so there is currently no new predicted indication. The uses recorded for this drug are listed below. They are the drug’s own recorded uses, not model candidates.
Quick overview
| Item | Content |
|---|---|
| New predicted indications | None (no model candidate scored 0.99 or higher) |
| Known uses recorded for this drug | 3 |
| Evidence level | Not applicable |
| Canada Market Status | Approved but not marketed (approvals on record: 1) |
| Number of DINs | 1 (marketed: 0) |
Known uses recorded for this drug
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| none | none |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| pediculus humanus capitis infestation |
| pediculus humanus corporis infestation |
| pthirus pubis infestation |
Canada Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 02125447 | R & C SHAMPOO WITH CONDITIONER | DORMANT |
Safety Considerations
- Possible contraindicated conditions (from the TxGNN knowledge graph, not label text): dermatitis, bronchial disease.
- Class toxicity: A toxicology review of pyrethroid poisoning (PMID 16180929) is relevant when PBO is combined with pyrethroids.
Please refer to the package insert for further safety information. No drug interaction records were found.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.